Floatz logo

Keppra

Stroke

Shanghai East HospitalPhase 4 / ApprovedActive
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
65/ 100

Competitive context

140 Active assets in the Stroke cohort.

Asset / SponsorPhaseRating
Tenecteplase
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Rivaroxaban
China National Center for Cardiovascular Diseases
Phase 4BBB
WARFARIN
China National Center for Cardiovascular Diseases
Phase 4BB
Plavix
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 4BB
Acetylsalicylic Acid
China National Center for Cardiovascular Diseases
Phase 4BB

View all 50 →

Same molecule, other indications

Keppra is also rated in:

Epilepsy, PartialDormant
A
Indicative ·
80 / 100
View asset →
Epilepsy, Tonic-clonicDormant
BBB
Indicative ·
78 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →